ATSP-3848

General Information


DRACP ID  DRACP05902

Peptide Name   ATSP-3848

Sequence  LTFEHYWAQLTS

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Induce apoptosis MDM2/MDMX Inhibitor



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  MDM2, MDMX

Affinity  MDM2: Ki=14.6 nM; MDMX: Ki=47.4 nM

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C71H98N16O20

Absent amino acids  CDGIKMNPRV

Common amino acids  LT

Mass  169204

Pl  5.36

Basic residues  1

Acidic residues  1

Hydrophobic residues  5

Net charge  0

Boman Index  -873

Hydrophobicity  -20

Aliphatic Index  73.33

Half Life 
  Mammalian: 0.8 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  635.45

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23946421

Title  Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

Doi 10.1073/pnas.1303002110

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.